{
  "id": 5503,
  "url": "https://nnemf.org/research/5503-modulation-of-antioxidant-enzyme-gene-expression-by-extremely",
  "title": "Modulation of antioxidant enzyme gene expression by extremely low frequency electromagnetic field in post-stroke patients.",
  "authors": [
    "Natalia Cichon",
    "Michal Bijak",
    "Ewelina Synowiec",
    "Elzbieta Miller",
    "Tomasz Sliwinski",
    "Joanna Saluk-Bijak"
  ],
  "journal": "Scandinavian journal of clinical and laboratory investigation",
  "year": "2018",
  "doi": "10.1080/00365513.2018.1542540",
  "pmid": "30755096",
  "abstract": "Oxidative stress plays the most important role in the pathogenesis of stroke. Extremely low frequency electromagnetic field (ELF-EMF) therapy may be complementary in post-stroke therapy, as it modulates oxidative stress. The aim of this study was to evaluate the messenger ribonucleic acid (mRNA) levels of certain antioxidant genes in post-stroke patients given ELF-EMF therapy. Forty-eight post-stroke patients were divided into two groups: an ELF-EMF group and a non-ELF-EMF group. All patients underwent the same program of physical therapy, but the ELF-EMF group was additionally given ELF-EMF treatment. In order to determine the level of gene expression, we evaluated the level of mRNA expression of catalase, superoxide dismutase, and glutathione peroxidase. We observed that after ELF-EMF therapy, the mRNA expression of the studied genes (CAT, SOD1, SOD2, GPx1, and GPx4) significantly increased, which enhanced the antioxidant defence of the body. ELF-EMF therapy intensifies the endogenous antioxidant system by increasing the mRNA expression of genes encoding antioxidant enzymes and enhances the effectiveness of post-stroke patient therapy.",
  "effect": "benefit",
  "evidence": "low",
  "extraction": {
    "studyType": "other",
    "studyTypeLabel": "Other",
    "effectDirection": "benefit",
    "evidenceLabel": "Low",
    "population": "Post-stroke patients",
    "sampleSize": "48",
    "exposure": "ELF <1 MHz",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "In 48 post-stroke patients, those receiving additional ELF-EMF therapy showed a significant increase in mRNA expression of CAT, SOD1, SOD2, GPx1, and GPx4 after therapy, compared with the non-ELF-EMF group. The authors interpret this as enhanced antioxidant defence and improved effectiveness of post-stroke therapy.",
    "outcomes": [
      "mRNA expression of antioxidant enzyme genes (CAT",
      "SOD1",
      "SOD2",
      "GPx1",
      "GPx4)",
      "Antioxidant defence/endogenous antioxidant system (as inferred from gene expression changes)"
    ],
    "limitations": [
      "No ELF-EMF exposure parameters reported (e.g.",
      "frequency",
      "intensity",
      "session duration).",
      "Study design details not provided in abstract (e.g.",
      "randomization",
      "blinding",
      "allocation method).",
      "Clinical outcomes are not described",
      "outcomes reported are gene expression measures."
    ],
    "keywords": [
      "extremely low frequency electromagnetic field",
      "ELF-EMF",
      "stroke",
      "post-stroke therapy",
      "oxidative stress",
      "antioxidant enzymes",
      "gene expression",
      "catalase",
      "superoxide dismutase",
      "glutathione peroxidase",
      "mRNA"
    ],
    "hubs": [
      {
        "slug": "occupational-exposure",
        "weight": "0.7",
        "reason": "ELF-EMF is studied, but this appears to be therapeutic exposure rather than occupational; hub match is weak."
      }
    ],
    "raw": "{\n  \"study_type\": \"other\",\n  \"exposure\": {\n    \"band\": \"ELF\",\n    \"source\": \"therapy\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Post-stroke patients\",\n  \"sample_size\": 48,\n  \"outcomes\": [\n    \"mRNA expression of antioxidant enzyme genes (CAT, SOD1, SOD2, GPx1, GPx4)\",\n    \"Antioxidant defence/endogenous antioxidant system (as inferred from gene expression changes)\"\n  ],\n  \"main_findings\": \"In 48 post-stroke patients, those receiving additional ELF-EMF therapy showed a significant increase in mRNA expression of CAT, SOD1, SOD2, GPx1, and GPx4 after therapy, compared with the non-ELF-EMF group. The authors interpret this as enhanced antioxidant defence and improved effectiveness of post-stroke therapy.\",\n  \"effect_direction\": \"benefit\",\n  \"limitations\": [\n    \"No ELF-EMF exposure parameters reported (e.g., frequency, intensity, session duration).\",\n    \"Study design details not provided in abstract (e.g., randomization, blinding, allocation method).\",\n    \"Clinical outcomes are not described; outcomes reported are gene expression measures.\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"extremely low frequency electromagnetic field\",\n    \"ELF-EMF\",\n    \"stroke\",\n    \"post-stroke therapy\",\n    \"oxidative stress\",\n    \"antioxidant enzymes\",\n    \"gene expression\",\n    \"catalase\",\n    \"superoxide dismutase\",\n    \"glutathione peroxidase\",\n    \"mRNA\"\n  ],\n  \"suggested_hubs\": [\n    {\n      \"slug\": \"occupational-exposure\",\n      \"weight\": 0.05,\n      \"reason\": \"ELF-EMF is studied, but this appears to be therapeutic exposure rather than occupational; hub match is weak.\"\n    }\n  ]\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/30755096/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=5503",
  "updated": "2026-02-14 08:45:48"
}